GRL093-22 is a potent and selective small molecule inhibitor of GRK5 (IC50=60 nM) and GRK6 (IC50=40 nM). Its application in research extends to cardiovascular diseases like heart failure and oncology areas such as multiple myeloma, with utility in both cellular and animal model studies.
Molekulargewicht:
576.62
Formel:
C33H29FN6O3
Target-Kategorie:
GRK,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
